CLINICAL_TRIALS
trial_result
· 2014-10-28
Clinical Trial Update: Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants [Phase 1]
Summary
A Phase 1 study assessed safety, tolerability, and pharmacokinetics of BG00010 (Neublastin) in participants with sciatica; the trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Sciatica | Phase 1 | Status: COMPLETED